Items Tagged ‘nibolumab’

January 9, 2018

FDA Approves Opdivo for Adjuvant Treatment of Melanoma


CancerConnect News: The United States Food and Drug Administration granted regular approval to the anti-PD1 monoclonal antibody, Opdivo (nivolumab) for the adjuvant treatment of patients with melanoma with involvement of lymph nodes or in patients with metastatic disease who have undergone complete resection. Opdivo was previously approved for the treatment of patients with unresectable or […]

View full entry

Tags: malignant melanoma, Melanoma, News, nibolumab, opdivo, Precision Cancer Medicine, Yervoy